13 results on '"Chen, Amy Y"'
Search Results
2. Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.
- Author
-
Lin CC, Fedewa SA, Prickett KK, Higgins KA, and Chen AY
- Subjects
- Aged, Aged, 80 and over, Chemoradiotherapy, Female, Humans, Laryngeal Neoplasms mortality, Laryngeal Neoplasms pathology, Male, Middle Aged, SEER Program, Treatment Outcome, United States epidemiology, Laryngeal Neoplasms surgery, Laryngeal Neoplasms therapy
- Abstract
Background: The treatment of patients with advanced stage laryngeal cancer includes surgery or concurrent chemoradiation (CRT). Although CRT has become more common in recent years, to the authors' knowledge, the effectiveness of complete CRT in improving survival over surgery has not been studied., Methods: The authors examined patients in the Surveillance, Epidemiology, and End Results (SEER)-Medicare claims-linked data set with locoregional laryngeal cancer who were diagnosed between 1997 and 2007. Multivariate Cox proportional hazard analyses were conducted to compare overall and cause-specific 5-year survival rates between treatment modalities, adjusting for patient sociodemographic and clinical characteristics. A propensity score-matched subcohort also was used to compare survival., Results: Of the 3212 patients in the study cohort, 42% underwent surgery and 18% underwent CRT. Only approximately one-quarter of patients who were treated with CRT completed the courses. In adjusted analyses, the authors were unable to reject the null hypothesis of no difference in 5-year all-cause or cause-specific mortality risk between patients treated with surgery and patients undergoing complete CRT (hazards ratio, 1.25 [95% confidence interval, 0.91-1.71; P = .16] and hazard ratio, 1.41 [95% confidence interval, 0.9-2.2; P = .14], respectively). Older age, not currently married, Medicaid eligibility, and prior cancer history were found to be associated with a higher risk of mortality (P<.05)., Conclusions: Patients with advanced laryngeal cancer who underwent complete CRT were found to have overall and cause-specific survival rates similar to those of patients undergoing surgery. However, a substantial percentage of patients who initiated CRT did not complete the course. Although CRT provides organ preservation, the benefits and trade-offs of CRT and total laryngectomy should be discussed fully with patients. The importance of completing the full course of CRT should be emphasized. Cancer 2016. © 2016 American Cancer Society. Cancer 2016;122:2845-2856. © 2016 American Cancer Society., (© 2016 American Cancer Society.)
- Published
- 2016
- Full Text
- View/download PDF
3. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
- Author
-
Zhu J, Fedewa S, and Chen AY
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell pathology, Combined Modality Therapy, Cross-Sectional Studies, Educational Status, Female, Humans, Laryngeal Neoplasms pathology, Male, Middle Aged, Neoplasm Invasiveness, Socioeconomic Factors, Treatment Outcome, United States, Carcinoma, Squamous Cell therapy, Chemoradiotherapy, Comorbidity, Laryngeal Neoplasms therapy, Laryngectomy
- Abstract
Objective: To investigate whether patients treated with laryngectomy had less comorbidity than those treated with chemoradiation, which could help explain the improved survival for the laryngectomy cohorts in recent studies., Design: Observational cross-sectional study., Patients: Patients receiving diagnoses of primary invasive advanced squamous cell carcinoma of the larynx between 2003 and 2008 were selected from the National Cancer Database, which collects information from more than 1400 facilities accredited by the American College of Surgeons' Commission on Cancer. Patient-level independent variables included age at diagnosis, sex, diagnosis year, race/ethnicity, primary payer status, and zip code-level education., Main Outcome Measures: Primary treatment information. The association between treatment and patient clinical, sociodemographic, and facility-level and zip code-level socioeconomic status variables were analyzed using univariate statistics and multivariate models. Charlson Deyo Comorbidity and The Washington University Head and Neck Comorbidity Index scores were calculated from the hospital face sheet., Results: The study demonstrated that receipt of treatment (chemoradiation vs total laryngectomy) was significantly associated with comorbidity. Treatment was not significantly associated with insurance status, race/ethnicity, or age. Patients with comorbidity were less likely to receive chemoradiation than subtotal or total laryngectomy, with a risk ratio (RR) of 0.84 (95% CI, 0.81-0.87) for patients with 1 or more comorbidities compared with those without any comorbidity, after controlling for factors such as tumor stage, age, race/ethnicity, insurance, and socioeconomic status. Patients were also less likely to receive chemoradiation than total laryngectomy if they had stage IV disease (RR, 0.81; 95% CI, 0.79-0.83) and if they had been diagnosed at a teaching or research institution (RR, 0.80; 95% CI, 0.77-0.84). Patients were more likely to receive chemoradiation if they were diagnosed after 2003 (RR, 1.37; 95% CI, 1.30-1.45) or if they lived in a zip code with a high percentage of high school graduates (RR, 1.1; 95% CI, 1.05-1.15)., Conclusions: This is the first study, to our knowledge, that demonstrates that patients with advanced laryngeal cancer with 1 or more comorbidities are more likely to receive surgery than chemoradiation compared with patients without any comorbidity, independent of numerous clinical and nonclinical variables among a large national cohort. A limitation of this study is the use of comorbidity data from the National Cancer Database, which gathers its information from hospital discharge face sheets. We recognize that the National Cancer Database may be an imperfect system for the collection of comorbidity data and encourage discussion on different methods to improve the system, including incorporating comorbidity data from the Surveillance, Epidemiology, and End Results Medicare Database and medical chart-based comorbidity data collection by cancer registrars.
- Published
- 2012
- Full Text
- View/download PDF
4. Patterns of extralaryngeal spread of laryngeal cancer: thyroid cartilage penetration occurs in a minority of patients with extralaryngeal spread of laryngeal squamous cell cancers.
- Author
-
Chen SA, Muller S, Chen AY, Hudgins PA, Shin DM, Khuri F, Saba NF, and Beitler JJ
- Subjects
- Female, Humans, Male, Neoplasm Invasiveness, Carcinoma, Squamous Cell pathology, Laryngeal Neoplasms pathology, Thyroid Cartilage pathology
- Abstract
Background: Laryngeal preservation programs for patients with advanced laryngeal squamous cell carcinomas (SCC) have generally excluded patients with T4 disease. The accuracy of preoperative imaging in evaluating thyroid cartilage penetration and extralaryngeal spread (ELS) has previously been questioned. Clinically, SCC spread into noncartilaginous structures may have less of a functional impact when compared with thyroid cartilage penetration. The current study was designed to characterize and quantify the routes and frequency of ELS., Methods: A total of 103 laryngectomy specimens with preoperative contrast-enhanced neck computed tomography scans were coded according to the observed extent of disease by pathological and radiological data. Previously irradiated tumors or those of pyriform sinus origin were omitted. Routes of spread were categorized as anterior (thyroid cartilage penetration), posterior (arytenoid cartilage destruction and thyroarytenoid space widening), inferior (conus elasticus penetration), and superior (base of tongue, thyrohyoid membrane or thyroid notch penetration involvement)., Results: Sixty-three cases of ELS were identified. Anterior spread by thyroid cartilage penetration occurred in 44% of all instances of ELS, followed by both inferior and posterior spread each representing 33% of ELS cases. Superior spread occurred with a frequency of 24%., Conclusions: Although thyroid cartilage penetration is a common route of ELS of glottic and supraglottic SCC, ELS into surrounding structures with thyroid cartilage penetration was found to occur in only 44% of the cases of ELS in the current study. As illustrated, advanced SCC spreads in a variety of pathways. Once these patterns are better understood and identified at the time of initial evaluation, subgroups of patients with ELS who may still be candidates for laryngeal preservation may be identified., (Copyright © 2011 American Cancer Society.)
- Published
- 2011
- Full Text
- View/download PDF
5. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
- Author
-
Chen AY, Fedewa S, and Zhu J
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Combined Modality Therapy statistics & numerical data, Cross-Sectional Studies, Databases, Factual, Female, Humans, Laryngeal Neoplasms mortality, Laryngectomy statistics & numerical data, Male, Middle Aged, Neoplasm Staging, Practice Patterns, Physicians', Retrospective Studies, Survival Rate, United States, Young Adult, Laryngeal Neoplasms pathology, Laryngeal Neoplasms therapy
- Abstract
Objective: To describe trends and 4-year survival rate of surgical and nonsurgical treatment for laryngeal cancer., Design: Observational cross-sectional study., Patients: A total of 131 694 cases of laryngeal cancer diagnosed from 1985 to 2007 identified from the National Cancer Database., Main Outcome Measures: Primary treatment information, including radiation therapy (RT), chemoradiation (CRT), and curative intent surgery, were identified. The association between treatment and the patient's clinical and nonclinical variables was analyzed using univariate and multivariate statistics. The 4-year survival rate was generated through Kaplan-Meier estimates, and multivariate Cox proportional hazard models were used to generate hazard ratios., Results: Among patients with early-stage cancer, the proportion receiving primary surgery increased (from 20% in 1985 to 33% in 2007), whereas the use of RT decreased from 64% to 52%. Patients with early-stage cancer who resided in areas with higher socioeconomic status (SES) zip codes, had private insurance, who were not African American, and who were treated at academic facilities were more likely to receive surgery. The 4-year survival rate for patients with early-stage laryngeal cancer treated with surgery was higher than the rate for those treated with RT (79% vs 71%). Among patients with advanced-stage cancer, the use of CRT increased from less than 7% to 45%, whereas the use of total laryngectomy decreased from 42% to 32%. The use of CRT was more common among patients who resided in areas with higher SES zip codes, had private insurance, and who were younger. The 4-year survival rates for patients with advanced laryngeal cancer treated with total laryngectomy, CRT, and RT were 51%, 48%, and 38%, respectively. Factors associated with an increased risk of death from advanced laryngeal cancer included receiving CRT and race/ethnicity., Conclusions: Among patients with early-stage laryngeal cancer, we observed an increasing proportion of primary surgical therapy during this study period. Among patients with advanced-stage cancer, we observed an increasing proportion of CRT. Not only were clinical factors associated with type of treatment, but select sociodemographic elements were also associated with treatment. Further investigation as to the decision-making process of patients with different sociodemographic backgrounds will assist in mitigating the differences in survival for this group of patients.
- Published
- 2011
- Full Text
- View/download PDF
6. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer.
- Author
-
Chen AY, Fedewa S, Pavluck A, and Ward EM
- Subjects
- Adolescent, Adult, Aged, Cancer Care Facilities statistics & numerical data, Carcinoma, Squamous Cell pathology, Databases as Topic, Female, Hospitals, Community, Humans, Laryngeal Neoplasms pathology, Laryngeal Neoplasms therapy, Laryngectomy, Male, Middle Aged, Registries, Survival Analysis, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell therapy, Hospitals, Teaching statistics & numerical data, Laryngeal Neoplasms mortality
- Abstract
Background: Because of the multidisciplinary nature of treatment for advanced laryngeal cancer, the authors hypothesized that treatment at high-volume teaching/research facilities is associated with improved survival., Methods: After exclusions, 19,326 patients who were diagnosed with advanced laryngeal cancer (stage III and IV) between 1996 and 2002 and who received treatment (chemoradiotherapy [CRT], total laryngectomy [TL], or radiotherapy [RT]) were analyzed from the National Cancer Database (NCDB). Facilities were classified into 6 groups (low-volume and high-volume teaching/research facilities, low-volume and high-volume community cancer centers, and low-volume and high-volume community facilities). Multivariate proportional hazards regression modeling was used to determine 90-day, 365-day, and 4-year hazard ratio (HR) estimates., Results: Treatment included TL (37.6%), CRT (29.4%), and RT alone (33%). Overall, 36.2% of patients were treated at high-volume teaching/research centers (average, 17.1 cases per year). Among all patients, 20% died within the first year. In multivariate models that were controlled for covariates, 90-day, 365-day, and 4 year HR estimates for death were lowest for high-volume teaching/research centers., Conclusions: Receiving treatment at high-volume teaching/research facilities was associated with improved survival. Undergoing total laryngectomy also was associated with improved survival. The current results suggested that the regionalization of care for patients with advanced-stage laryngeal cancer has occurred, because most patients were treated either at high-volume teaching/research facilities or at high-volume community cancer centers. Future studies should investigate the factors associated with better survival at high-volume teaching/research facilities, such as quality of care, processes of care, and referral patterns., (© 2010 American Cancer Society.)
- Published
- 2010
- Full Text
- View/download PDF
7. Health literacy and health care in an inner-city, total laryngectomy population.
- Author
-
Beitler JJ, Chen AY, Jacobson K, Owens A, Edwards M, and Johnstone PA
- Subjects
- Cohort Studies, Educational Status, Female, Georgia, Health Knowledge, Attitudes, Practice, Humans, Laryngeal Neoplasms pathology, Laryngeal Neoplasms psychology, Male, Middle Aged, Quality of Life, Speech, Alaryngeal, Surveys and Questionnaires, Urban Health, Health Literacy, Laryngeal Neoplasms surgery, Laryngectomy, Patient Education as Topic, Urban Health Services
- Abstract
Background: Literacy in the head and neck cancer patient has been understudied. Health literacy (HL) is "the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health care decisions." Limited HL skills reduce access to health care. We surveyed our patients who underwent total laryngectomy (TL) to evaluate their HL., Methods: Patients who had undergone TL at Grady Hospital (Atlanta, GA), an inner-city hospital, between 1988 and 1992 were identified. Sociodemographics, general health quality of life, HL, and alaryngeal voice assessment were performed., Results: Thirty patients were eligible but 14 could not be located, 4 refused, and 4 were deceased or too ill to participate. More than one third of the remaining patients had severely inadequate HL scores., Conclusion: Patients who underwent TL have a high incidence of becoming lost in the system as well as having inadequate health care literacy. Health literacy may be important when considering TL.
- Published
- 2010
- Full Text
- View/download PDF
8. Impact of treating facilities' volume on survival for early-stage laryngeal cancer.
- Author
-
Chen AY, Pavluck A, Halpern M, and Ward E
- Subjects
- Aged, Cancer Care Facilities statistics & numerical data, Female, Humans, Laryngeal Neoplasms pathology, Laryngeal Neoplasms therapy, Male, Socioeconomic Factors, United States epidemiology, Hospitals statistics & numerical data, Laryngeal Neoplasms mortality
- Abstract
Background: Treatment at a high-volume facility has been associated with better outcomes in a variety of conditions. The relationship between volume and survival from laryngeal cancer has not been examined previously., Methods: A total of 11,446 early-stage laryngeal cancer patients (1996-1998) who reported to the National Cancer Database (NCDB) were analyzed. Proportional hazards regression was used to assess the relationship between survival and treatment volume controlling for other factors associated with survival., Results: Treatment at low-volume facilities was associated with a significantly increased likelihood of death (hazard ratio 1.20, 95% CI 1.04-1.38). Surgical resection, as compared with radiation treatment, was associated with lower mortality (HR 0.74, 95% CI 0.69-0.80)., Conclusion: This study is the first to assess the relationship between survival and treatment volume in laryngeal cancer. Treatment at a high-volume facility is associated with better survival. Surgical treatment rather than radiation was also associated with better survival, although we could not control for confounders that may bias treatment selection.
- Published
- 2009
- Full Text
- View/download PDF
9. Recent changes in the treatment of patients with advanced laryngeal cancer.
- Author
-
Genden EM, Ferlito A, Rinaldo A, Silver CE, Fagan JJ, Suárez C, Langendijk JA, Lefebvre JL, Bradley PJ, Leemans CR, Chen AY, Jose J, and Wolf GT
- Subjects
- Age Factors, Antineoplastic Agents economics, Antineoplastic Agents therapeutic use, Deglutition Disorders psychology, ErbB Receptors antagonists & inhibitors, Humans, Laryngeal Neoplasms pathology, Laryngeal Neoplasms psychology, Laryngectomy economics, Neoadjuvant Therapy economics, Protein Kinase Inhibitors therapeutic use, Quality of Life, Xerostomia psychology, Laryngeal Neoplasms therapy
- Abstract
Since the original data from the Department of Veterans Affairs Laryngeal Cancer Study Group demonstrated that nonsurgical therapy could achieve survival rates comparable to total laryngectomy in selected cases, there has been a progressive increase in employment of nonsurgical therapy for the management of advanced laryngeal cancer. Both neoadjuvant chemotherapy followed by conventionally fractionated or hyperfractioned radiotherapy for chemotherapy responders, or simultaneously administered chemoradiation has resulted in a significant number of patients who achieved cure while preserving their larynges. Nevertheless, combined chemotherapy and external beam radiation is associated with a variety of acute and chronic sequelae that can have a debilitating impact on function and quality of life. Although no therapeutic option is without risk, the decision regarding the modality of therapy for a patient with advanced laryngeal cancer should prompt a careful review of the current surgical techniques available for treatment. Data on quality of life and aging, as well as advances in minimally invasive surgical techniques, are available today that were not available at the time of the Veterans study. Selection of optimal therapy is often complex and raises the question whether the pendulum may have swung too far in the direction of nonsurgical therapy for advanced laryngeal cancer. This article reviews the current options available for a patient with advanced laryngeal cancer and discusses the impact of therapy., (Copyright (c) 2007 Wiley Periodicals, Inc.)
- Published
- 2008
- Full Text
- View/download PDF
10. Factors predictive of survival in advanced laryngeal cancer.
- Author
-
Chen AY and Halpern M
- Subjects
- Aged, Combined Modality Therapy, Female, Humans, Laryngeal Neoplasms pathology, Laryngeal Neoplasms therapy, Male, Middle Aged, Neoplasm Staging, Odds Ratio, Registries, Retrospective Studies, Severity of Illness Index, Survival Analysis, Survival Rate, United States epidemiology, Laryngeal Neoplasms mortality
- Abstract
Objective: To determine the factors predictive of improved survival among patients with advanced laryngeal cancer., Design: National hospital-based cancer registry., Patients: Patients treated with total laryngectomy (TL), radiation therapy alone (RT), or combined chemotherapy and radiation therapy (chemo-RT)., Results: Of the 10,590 patients meeting the initial inclusion criteria, 7,019 had appropriate nonmissing values in all study variables and were included in the analysis. Overall, TL was significantly associated with increased likelihood of survival compared with RT or chemo-RT (P<.001). Among patients with stage III cancer, TL and chemo-RT had similar impacts on survival (each showed increased survival compared with RT), whereas TL was associated with significantly greater survival than chemo-RT or RT among patients with stage IV disease (P<.001). Overall survival was also decreased among men, black patients (compared with white patients), and patients with Medicare or Medicaid or those who were uninsured (compared with those with private insurance)., Conclusions: Among patients with the most advanced disease (stage IV), TL was associated with increased survival compared with chemo-RT or RT, whereas both TL and chemo-RT improved survival over RT among patients with stage III cancer. Insurance type and black race also showed significant associations with survival, which may reflect barriers in access to care (P<.001).
- Published
- 2007
- Full Text
- View/download PDF
11. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis?
- Author
-
Chen AY, Schrag NM, Halpern M, Stewart A, and Ward EM
- Subjects
- Adolescent, Adult, Aged, Carcinoma, Squamous Cell therapy, Cohort Studies, Diagnosis, Differential, Female, Humans, Laryngeal Neoplasms therapy, Male, Middle Aged, Neoplasm Staging, Prospective Studies, Retrospective Studies, United States, Carcinoma, Squamous Cell pathology, Insurance, Health statistics & numerical data, Laryngeal Neoplasms pathology
- Abstract
Objective: To examine whether patients with no insurance or Medicaid are more likely to present with advanced-stage laryngeal cancer., Design: Retrospective cohort study from the National Cancer Database, 1996-2003., Setting: Hospital-based practice., Participants: Patients with known insurance status diagnosed as having invasive laryngeal cancer at Commission on Cancer facilities (N = 61 131) were included. Adjusted and unadjusted logistic regression models analyzed the likelihood of presenting at a more advanced stage., Main Outcome Measures: Overall stage of laryngeal cancer (early vs advanced) and tumor size (T stage) at diagnosis., Results: Patients with advanced-stage laryngeal cancer at diagnosis were more likely to be uninsured (odds ratio [OR], 1.97; 95% confidence interval [CI], 1.79-2.15) or covered by Medicaid (OR, 2.40; 95% CI, 2.21-2.61) compared with those with private insurance. Similarly, patients were most likely to present with the largest tumors (T4 disease) if they were uninsured (OR, 2.92; 95% CI, 2.60-3.28) or covered by Medicaid (OR, 3.97; 95% CI, 3.56-4.34). Patients who were black, between ages 18 and 56 years, and who resided in zip codes with low proportions of high school graduates or low median household incomes were also more likely to be diagnosed as having advanced disease and/or larger tumors., Conclusions: Individuals lacking insurance or having Medicaid are at greatest risk for presenting with advanced laryngeal cancer. Results for the Medicaid group may be influenced by the postdiagnosis enrollment of uninsured patients. It is important to consider the impact of insurance coverage on stage at diagnosis and associated morbidity, mortality, quality of life, and costs.
- Published
- 2007
- Full Text
- View/download PDF
12. Changes in treatment of advanced laryngeal cancer 1985-2001.
- Author
-
Chen AY, Schrag N, Hao Y, Flanders WD, Kepner J, Stewart A, and Ward E
- Subjects
- Aged, Cancer Care Facilities statistics & numerical data, Combined Modality Therapy, Female, Hospitals, Community statistics & numerical data, Hospitals, Teaching statistics & numerical data, Humans, Laryngectomy statistics & numerical data, Laryngectomy trends, Male, Middle Aged, United States, Antineoplastic Agents therapeutic use, Laryngeal Neoplasms drug therapy, Laryngeal Neoplasms radiotherapy, Medical Oncology trends
- Abstract
Objective: In 1991, a randomized study was published and demonstrated that use of nonsurgical therapy (chemoradiation) provided similar survival to total laryngectomy (the gold standard) for patients with advanced-stage laryngeal cancer. The purpose of this study was to assess how treatment of advanced laryngeal cancer was influenced by such developments in non-surgical therapy., Study Design: Patterns of care study using National Cancer Database (1985-2001)., Results: The percentage of advanced-stage patients treated with chemoradiation increased from 8.3% to 20.8% while the proportion treated with radiation alone decreased from 38.9% to 23.0%. Use of chemoradiation increased at a significantly faster rate after the 1991 publication at both community cancer centers and teaching research facilities. The use of total laryngectomy decreased slightly during this period., Conclusions: The use of chemoradiation increased after the 1991 publication. It was impossible to determine from the NCDB whether additional patients who could benefit from chemo-RT were not offered or did not complete this treatment option. We recommend that treatment recommendations discussed at tumor boards be recorded in cancer registries.
- Published
- 2006
- Full Text
- View/download PDF
13. Factors influencing long-term survival following salvage total laryngectomy after initial radiotherapy or conservative surgery.
- Author
-
Fowler BZ, Muller S, Chen AY, and Johnstone PA
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma mortality, Combined Modality Therapy, Disease-Free Survival, Female, Humans, Laryngeal Neoplasms mortality, Male, Middle Aged, Retrospective Studies, Survival Rate, Carcinoma surgery, Laryngeal Neoplasms surgery, Laryngectomy, Neoplasm Recurrence, Local surgery, Salvage Therapy
- Abstract
Background: This retrospective study investigated survival outcomes of salvage total laryngectomy (STL) after initial radiation therapy (RT) or larynx conservation surgery (CS) at an academic center., Methods: A chart review yielded 64 patients with STL: 53 with RT failures, six with CS failures, and five after RT + CS. Median potential follow-up after STL was 9.4 years (mean, 9.2 years; range, 0.3-17.4 years)., Results: Five- and 10-year actuarial overall survival (OS) after STL was 65.2% and 37.7%, respectively. Mean survival after STL was 7.2 years (median, 6.8 years; range, 0.2-17.4 years). No significant survival difference was found between the three treatment groups (p = .50). For 21 patients with nodes assessed at STL, 9-year OS was 45.4% for patients with N0 disease versus 26.7% for patients with N+ disease (p = .25)., Conclusion: These data suggest that STL after radiation failure is associated with equivalent long-term survival as STL after RT + CS or after failure of CS alone., (Copyright 2005 Wiley Periodicals, Inc.)
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.